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Lipopolysaccharide (LPS) binding protein (LBP) is a key
serum factor that mediates LPS activation of mononuclear
cells. In the presence of LBP, 1/1,000 the concentration of
LPS is sufficient to activate peripheral blood monocytes.
Previous studies with Kupffer cells have shown a variable
effect of serum on LPS activation of these cells and led to
the conclusion that, unlike extrahepatic mononuclear cells,
Kupffer cells do not respond to LPS in an LBP-dependent
fashion. Because there are multiple components in serum
other than LBP that might affect LPS activation, these
reports with serum are difficult to interpret. To investigate
the specific role of LBP in LPS activation of Kupffer cells, we
produced a functional recombinant rat LBP using a baculo-
virus expression system, which we used to selectively
examine the role of LBP’s on Kupffer-cell function. Isolated
Kupffer cells exposed to increasing concentrations of LPS
(0, 1, 10 ng/mL) showed a dose-dependent increase in
TNF-a production, which was augmented and accelerated
by the presence of LBP. The effects of LBP on Kupffer cell
activation by LPS are dependent on a functional Toll-like
receptor 4 (Tlr 4) because Kupffer cells from C3H/HeJ mice
failed to respond to LPS in the presence of LBP. LBP plays an
important role in mediating Kupffer cell activation by LPS,
and these effects are dependent on the presence of function-
ing Tlr 4. (HEPATOLOGY 2000;31:932-936.)
Endogenous lipopolysaccharides (LPS) have been impli-
cated as a cofactor in promoting liver injury in many models
of liver injury, including alcoholic hepatitis.1,2 In the Tsuko-
moto and French model of rat alcoholic hepatitis,3 the degree
of liver injury is diminished by treatment with either antibiot-
ics, lactobacillus, or polymixin, all of which decrease endog-
enous LPS.4,5 In this model, Kupffer cells, when activated by
LPS, play a prominent role in promoting liver injury.6 Despite
its potentially critical importance, the molecular mechanism
by which Kupffer cells are activated by LPS remains largely
unknown.
In peripheral blood monocytes, the pathway of LPS activa-
tion has been recently delineated. In serum, LPS binds to
LPS-binding protein (LBP), which is a 60-kd acute-phase
protein produced by hepatocytes.7,8 This LPS-LBP complex
then binds to membrane CD14 resulting in cell activation,
nuclear translocation of NF-kb, and production of cytokines
such as TNF-a.9,10 The critical importance of LBP during in
vivo responses to LPS and gram-negative bacteria is clearly
shown by the inability of LBP knock-out mice to fight
intraperitoneal infections11 as well as the ability of anti-LBP
monoclonal antibodies to prevent lethality in the LPS/
galactosamine model of endotoxemia.12 Multiple lines of
evidence suggest that the mechanisms by which LPS activates
Kupffer cells may differ from those found in blood mono-
cytes. Some authors have suggested that LPS activation in
Kupffer cells is not mediated via the LBP/CD14 pathway
hypothesized for blood monocytes.13,14 Support for this idea
stems from reports showing relatively low levels of CD14
expression in resting Kupffer cells compared with RAW 264.7
cells (murine macrophage cell line) and peritoneal macro-
phages.15 Furthermore, in some studies, LPS activation of
Kupffer cells, unlike that in peripheral blood monocytes, is
not augmented by the addition of serum, suggesting that the
LBP found in serum may act differently in Kupffer cells.13,14
Because serum contains multiple factors that may alter LPS
activation, we sought to focus on LBP’s role in Kupffer cell
activation by performing experiments using recombinant rat
LBP. In addition, because Kupffer cells express relatively low
levels of CD14 in the resting state, we sought to examine the
role of another candidate LPS receptor, the Toll-like receptor
4 (Tlr 4), in mediating the effects of LBP on LPS activation of
Kupffer cells.
MATERIALS AND METHODS
Reagents. LPS from Escherichia coli (055:B5) was purchased from
Sigma (St Louis, MO), and pronase was obtained from Boehringer
Mannheim (Indianapolis, IN).
Recombinant Rat LBP. Recombinant rat LBP was produced using
the baculovirus expression system. Briefly, the full-length rat LBP
complementary DNA (cDNA)16 was cloned in frame into
pBluebacHis2c (Invitrogen, Carlsbad, CA) and used in conjunction
with the linearized defective baculovirus DNA, Bac-N-Blue (Invitro-
gen, Carlsbad, CA) to cotransfect Sf9 insect cells. Recombinant viral
clones were analyzed and selected using polymerase chain reaction
(PCR) and plaque assay. Optimization of protein production after
viral infection of Sf9 cells was carried out with Western blot analysis
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of cell pellets and supernatants using the anti-Xpress antibody
(Invitrogen, Carlsbad, CA), which recognizes an 8 amino acid
epitope in the amino terminus of the recombinant fusion protein. A
single 60-kd protein consistent with the predicted size of rat LBP is
seen both in the cell lysate and supernatant by Western blot (Fig.
1A). The recombinant fusion protein also has a 6-histidine tag in the
amino terminus that allows purification of the protein with metal
affinity chromatography. Although a single protein is purified using
a Nickel column (Fig. 1B and 1C), the binding of the protein on the
column requires denaturing conditions that may affect the activity of
the protein. Therefore, for the experiments in this article, the
supernatants of baculovirus cultures containing the recombinant
LBP are used. As control, an irrelevant protein CAT (chlorampheni-
col acetyltransferase) cloned in the same vector, pBluebacHis2, was
also used to cotransfect Sf9 cells in an identical manner as LBP to
produce control viral clones. Identical quantities of supernatants
from these clones were used as controls for all experiments. For all
the experiments, the amount of LBP and control CAT supernatant
was 3% of the total volume in the experimental condition. Previous
experiments with isolated Kupffer cells have shown that the peak
TNF-a levels in response to LPS (1 ng/mL and 10 ng/mL) were
achieved with the addition of 3% to 10% of LBP. High volume
production of both recombinant proteins were performed in serum-
free conditions by infecting High Five insect cells (Invitrogen,
Carlsbad,CA) in Excell 400 media ( JRH Biosciences, Lenexa, KS).
The intact biological activity of the recombinant LBP was shown by
its ability to augment IL-6 production in RAW 264.7 cells in
response to LPS (Fig. 2).
Isolation and Culture of Kupffer Cells. Kupffer cells were isolated
from male Sprague-Dawley rats (Harlan Sprague-Dawley) weighing
200 to 300 grams using the standard techniques of pronase
perfusion17 followed by differential centrifugation using Percoll
(Pharmacia, Uppsala, Sweden).18 All animals received humane care
in compliance with the regulations of the University of Michigan
and in accordance with the guidelines set forth by the National
Institute of Health Guide for the Care and Use of Laboratory
Animals. Briefly, livers were perfused through the portal vein with
Gey’s Balanced Salt Solution (GBSS, Gibco BRL, Gaithersburg, MD)
followed by GBSS with 0.2% pronase E. The liver was then excised
and minced before incubation with GBSS/pronase solution with
continuous stirring at 37°C for 60 minutes. DNase (0.8 µg/mL) was
added to prevent cell clumping. The liver slurry was filtered through
gauze mesh and washed with culture media and centrifuged at 600g
for 5 minutes 2 times. Cells were resuspended in PBS with DNase
(0.8 µg/mL). Cells were further purified using a discontinuous
Percoll gradient of 25% and 50% Percoll as described in detail by
Pertoft and Smedsrod.19 Purified nonparenchymal cells were washed
and cultured in media containing Williams E medium supplemented
with 100,000 U/L penicillin, 100 mg/L streptomycin, 15 mmol/L
HEPES, and 1026 mol/L insulin. Kupffer cells were enriched by
differential adherence to tissue culture plates. Cells (either 1.6 3 106
cells/well in a 24-well plate or 4.0 3 105 cells/well in a 96-well plate)
were plated in tissue culture plates at 37°C for 1/2 hour before
washing and incubating in tissue culture media containing 5% FCS
overnight. These cells were approximately 80% pure for Kupffer
cells as estimated by their ability to ingest latex beads. Cell viability
was always greater than 90% as assessed by trypan blue. All
experiments were subsequently performed after washing the cells 3
times with serum free media.
All the experiments presented in this article were performed
using Kupffer cells isolated by the method described above with the
exception of the ones isolated with counterflow elutriation. For
these cells, portal vein perfusion with pronase and digestion were
carried out as described earlier. However, after the liver slurry was
filtered through gauze and centrifuged, cells were resuspended in
GBSS/0.8 µg/mL DNAse and elutriated before plating on tissue
culture plates. A Beckman J2/21ME centrifugal elutriator (Beckman
Instruments, Palo Alto, CA) with a JE-6B rotor at 4°C was used. The
flow rate was calibrated at the start of each experiment. Kupffer cell
viability was assessed with trypan blue and for purity by their ability
to ingest latex beads. Kupffer cells were plated overnight at a
concentration of 5 3 105 cells/well in a 24-well plate. Cells were
washed 3 times with serum free media before all experiments.
Identical procedures were used to isolate mice Kupffer cells from
6- to 8-week-old C3H/OuJ and C3H/HeJ mice ( Jackson Laboratory,
Bar Harbor, ME) with the exception that the inferior vena cava was




FIG. 1. (A) Western blot analysis of lysates (LYS) of cell pellets and
supernatant (SUP) from Sf9 insect cells infected with recombinant LBP
baculovirus at a Multiplicity of Infection (MOI) of 14 shows a 60-kd protein
in both the cell pellet and supernatant. (B and C) Coomassie stain of SDS
PAGE and Western blot showing the purification of recombinant LBP over a
Nickel Column. All the fractions, lysate (LYS), run through (RT), washes 1
and 2 (W1 and W2), and elutions (A,B,C,D) were collected and run
simultaneously on 2 gels. One gel was stained with Coomassie stain and the
other immunoblotted with the Anti-Xpress antibody (Invitrogen, Carlsbad,
CA). Cell pellets were lysed using a freeze-thaw lysis in the presence of
protease inhibitors and bound to a Nickel Column (Qiagen,Valencia, CA)
under denaturing conditions containing 8 mol/L Urea and 5 mmol/L
imidazole, pH 8.0. The column was washed with 10 mmol/L imidazole and
eluted with 250 mmol/L imidazole (Sigma, St. Louis, MO).
FIG. 2. RAW 267.4 cells were plated in a 24-well plate at a concentration
of 5 3 105 cells/mL. Cells were incubated with increasing concentrations of
LPS (0, 1, 10 ng/mL) in the presence of either the irrelevant control protein
(CTRL) or recombinant LBP (LBP) for 6 hours. Supernatants were assayed
for mouse IL-6 by ELISA. All the experimental conditions were performed in
triplicate. This is a representative graph from the 3 experiments performed.
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ELISA. Mouse IL-6 and TNF-a were measured by ELISA using the
following antibodies: antimouse IL-6 antibody, MP5-20F3, biotinyl-
ated antimouse IL-6, MP5-32C11, antimouse TNF-a antibody,
G281-2626, and biotinylated antimouse TNF-a, MP6-XT3 from
Pharmingen (San Diego, CA) per the manufacturer’s instructions.
Recombinant mouse IL-6 and TNF-a from Pharmingen (San Diego,
CA) were used for the standard. Rat TNF-a levels were measured
with a rat TNF ELISA kit (Biosource, Camarillo, CA) per manufac-
turer’s instructions.
Western Blots. Total protein was measured with the BCA protein
assay method (Pierce Chemical, Rockford, IL). Cell extracts and
supernatants were separated by SDS-PAGE using a 10% to 12.5% gel
under reducing condition using the methods of Laemmli.20 Transfer
was carried out electrophoretically by the methods of Towbin et
al.,21 to nitrocellulose (Schleicher and Schuell). The membrane was
probed with a primary antibody followed by a horseradish peroxidase-
linked secondary antibody. Detection was carried out with the ECL
western blotting kit (Amersham, UK).
Polymerase Chain Reaction. Total RNA was isolated by standard
methods with Trizol (Gibco BRL, Rockville, MD).22 Reverse transcrip-
tion PCR was carried out as previously described.16 The conditions
for PCR amplification were as follows: 94°C for 1 minute, 57°C for 2
minutes, and 72°C for 3 minutes per cycle for 30 cycles. For each
reaction, 500 ng of total RNA was used for reverse transcription and
used as the template. The primers for mouse Tlr 4 were designed




The primer location span from 2,315 base pairs (bp) to 2,633 bp
to create a PCR product of 318 base pairs.
Statistical Analysis. Data were analyzed using analysis of variance
and 2-tail Student’s t test when the data had a normal distribution
(Statview program, Abacus Concepts/SAS Institute, Cary, NC).
Statistical significance was assigned at a P value of , .05. All the
figures are graphed with the mean 6 standard error.
RESULTS
LBP Augments Kupffer Cell Interactions with LPS. Kupffer cells
were isolated by differential adherence and incubated with
varying doses of LPS (0, 1, 10 ng/mL) in the presence of
either recombinant LBP or irrelevant control protein (CTRL)
for 6 hours in serum-free media. Supernatants were then
harvested and assayed for TNF-a by ELISA. Kupffer cells
responded to increasing concentrations of LPS in the absence
of LBP but the addition of LBP resulted in significantly more
total TNF-a production (P , .01) in response to LPS at both
1 ng/mL and 10 ng/mL (Fig. 3). Under the identical condi-
tions, normal rat serum (3%) and media alone with no
additives were also used (data not shown). Similar levels of
TNF-a were produced with either media alone or the
irrelevant control protein. Normal rat serum had a variable
effect on TNF-a production by Kupffer cells in response to
LPS with some experiments showing more TNF-a produc-
tion than media alone and some showing less TNF-a produc-
tion than media alone at the LPS doses of 1 ng/mL and 10
ng/mL. In some of the experiments, 100 ng/mL of LPS was
also tested, and even at these higher concentrations of LPS,
there was a significant increase in TNF-a production with the
addition of LBP.
To assess whether an alternate method of Kupffer cell
enrichment would alter the effect of LBP on LPS activation of
Kupffer cells, Kupffer cells were isolated and enriched using
counterflow elutriation. Similar results were found on the
effect of LBP on Kupffer cell response to LPS in Kupffer cells
isolated by counterflow elutriation (Fig. 4). The relative
increase in TNF-a production at LPS 1 ng/mL and 10 ng/mL
seems greater, suggesting that there are less LBP-independent
pathways of LPS activation in the elutriated Kupffer cells.
This may be a result of less contamination in the elutriated
Kupffer cells by other types of nonparenchymal cells.
LBP Decreases the Amount of Time Required for Kupffer Cells to
Interact With LPS. One potential mechanism by which LBP
can augment Kupffer cell responses to LPS may be via its
ability to accelerate the interaction of LPS with its receptor.
To examine this possibility, we repeated the experiments but
limited the exposure time of LPS with Kupffer cells. Isolated
Kupffer cells were exposed to 10 ng/mL of LPS in the
presence and absence of LBP for limited periods of time (5,
10, or 60 minutes). After the exposure time to LPS, the
supernatant was replaced with media alone containing poly-
mixin (50 U/mL) to block the actions of any remaining LPS.
The cells remained in culture for a total of 6 hours from the
time LPS was added. Supernatants were then collected for
TNF-a quantitation. As noted in Fig. 5, near maximal TNF-a
FIG. 3. TNF-a production by Kupffer cells exposed to LPS in the
presence of either an irrelevant control protein (CTRL) or recombinant LBP
(LBP). All experiments were carried out in triplicate and repeated 3 times.
This is a representative graph of the experimental results.
FIG. 4. TNF-a production by Kupffer cells isolated by counterflow
elutriation.
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production was noted after 5 minutes of exposure in the
presence of LBP, which was not achieved in the absence of
LBP.
The Effects of LBP on Kupffer Cell Activation by LPS Require a
Functional Toll-like Receptor 4. To examine the role of Tlr 4 in
mediating the effects of LBP on Kupffer cell activation by LPS,
we carried out experiments using Kupffer cells isolated from
either C3H/HeOuJ mice, which carry the wildtype Tlr 4 gene,
or C3H/HeJ mice, which carry a mutant Tlr 4 gene. Isolated
Kupffer cells from C3H/HeOuJ and C3H/HeJ mice have both
CD14 and Tlr 4 (Fig. 6A and 6B) as shown by Western blot
and PCR, respectively. However, as shown by sequence
analysis (Fig. 6C) of the Tlr 4 PCR product, C3H/HeJ mice
have a mutation in the Tlr 4 message that leads to a dominant
negative receptor product.
Isolated Kupffer cells from C3H/HeOuJ mice respond to
LPS in a dose-dependent manner similar to that seen with
Kupffer cells isolated from normal rat livers (Fig. 7). Further-
more, the addition of LBP augments this response as was seen
with normal rat Kupffer cells. In contrast, Kupffer cells from
C3H/HeJ mice did not produce any detectable levels of
TNF-a in response to the same doses of LPS, and this lack of
activation is not altered by the addition of LBP.
DISCUSSION
We have shown in the current studies that, although
Kupffer cells can be activated by low concentrations of LPS in
the absence of LBP, the presence of LBP greatly augments this
response. Given identical cell numbers and a set period of
time, more TNF-a is produced in response to LPS if LBP is
present. This effect is particularly important at low concentra-
tions of LPS such as 1 ng/mL where a greater than two-fold
increase in the total amount of TNF-a is measured over 6
hours of incubation. Interestingly, unlike RAW 264.7 cells, a
persistent effect of LBP is noted at even higher concentrations
of LPS (.1 ng/mL). The explanation for this difference
between the 2 cell types is not clear. The effect of LBP on
Kupffer cell activation, however, appears to be in part
explained by the fact that LBP’s presence decreases the
amount of time needed for LPS to interact with Kupffer cells.
After 5 minutes of exposure to LPS, Kupffer cells produce
significantly more TNF-a in the presence of LBP than in its
absence. This property of LBP is consistent with previous
reports describing LBP as a lipid-transferring protein greatly
accelerating the transfer of monomeric LPS to mCD14 and
sCD14 as well as high density lipoprotein.23-25
The LPS receptor on Kupffer cells that mediates the effects
of LPS and LBP remains uncertain. Although membrane
CD14 is important in mediating the effects of LPS/LBP
complexes on peripheral blood monocytes, it is unlikely to be
the receptor that can transmit LPS-induced signals across a
cell membrane. Because mCD14 is anchored to the cell
surface only by a glycosylphosphatidylinositol linkage, it
lacks a transmembrane component and thus the ability to
transduce cytoplasmic signals.26,27 It has long been postulated
that mCD14 might act to shuttle LPS/LBP to yet another
FIG. 5. TNF-a production by Kupffer cells with limited exposure time to
LPS in the presence of either the irrelevant control protein (CTRL) or
recombinant LBP (LBP). Each condition was performed in triplicate, and the
experiment was repeated twice.
A
B
FIG. 6. (A) CD14 expression in isolated Kupffer cells before experimenta-
tion in C3H/HeOuJ and C3H/HeJ mice. Western blots performed using
monoclonal rat antimouse CD14 antibody, rmC5-3 (Pharmingen, San Diego,
CA), shows a 55-kd protein band. (B) Tlr 4 PCR of negative (2, no template)
and positive (1, RAW 264.7 cell cDNA) controls, and cDNA from livers of
C3H/HeOuJ and C3H/HeJ mice show the 318-bp band. (C) Sequence
analysis of the PCR band after cloning into a TA vector (Invitrogen, Carlsbad,
CA) shows the mutation at amino acid 712 in the C3H/H3J cDNA.
FIG. 7. TNF-a production by isolated Kupffer cells from C3H/HeOuJ
mice that were exposed to increasing concentrations of LPS in the presence
of either the control protein (CTRL) or recombinant LBP (LBP). All
conditions were carried out in triplicate, and the entire experiment was
repeated 3 times. Identical experiments carried out in C3H/HeJ Kupffer cells
did not yield any detectable TNF-a (not pictured).
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transmembrane receptor. Recently, it has been proposed that
this candidate LPS receptor may be of the Toll-like receptor
family, specifically Tlr 4.27-29 Toll is a transmembrane protein
found in Drosophila, which is important in the host defense
against fungal infections. Because signaling through the
Drosophila Toll was found to be via the NF-kb–like pathway,
it was suspected that this receptor system may be important
in human innate immunity.30 Subsequently, a number of
human homologues of Toll were identified and named
Toll-like receptors.31,32 Evidence supporting Tlr 4’s role as a
LPS receptor stems from in vitro cell transfection experiments
utilizing human Tlr 4 constructs.27 In these experiments,
transfection of Tlr 4 confers LPS responsiveness in HEK 293
cells, which is augmented by the addition of sCD14. Further-
more, in mice, Tlr 4 knockout mice and naturally occurring
Tlr 4 mutants (C3H/HeJ and C57BL/10SScCr mice) are not
responsive to LPS in vivo. The C3H/HeJ mice have a missense
mutation in the third exon of the Tlr 4 gene that replaces a
proline with histidine at position 712 of the polypeptide
chain. This change results in a dominant negative mutant
receptor.28
Our results suggest that Kupffer cells from C3H/OuJ mice
have Tlr 4 mRNA expression and respond normally to LPS.
LBP augments the response to LPS in a manner similar to that
found in normal rats. Kupffer cells from C3H/HeJ mice, in
contrast, express Tlr 4 mRNA that have the missense muta-
tion and do not respond to LPS; this effect cannot be
corrected or altered by presence of LBP, suggesting that an
intact Tlr 4 receptor is necessary for the activities of LBP on
LPS activation. The presence of CD14 on Kupffer cells from
both strains of mice does not alter the need for an intact Tlr 4
receptor, supporting the hypothesis that Tlr 4 signaling
occurs downstream of LBP and CD14.
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